Movement Disorders

Diet linked to gut microbes and disease progression in sleep disorder

An observational study followed 287 people with a sleep disorder for a median 4.2 years and linked dietary patterns to later brain disease.

Figure 1 from Movement Disorders
Open the figure at full size
Figure 1. Xie et al.
Cohort study of 287 patients with isolated REM sleep behavior disorder, median 4.2 yearsPopulations

456 participants

Limit: Early cognitive and autonomic symptoms may change diet, rather than diet influencing progression

Follow

Researchers recruited 287 people with isolated rapid eye movement sleep behaviour disorder and 208 age- and sex-matched controls for an observational study. This disorder involves acting out dreams. They assessed diet using food questionnaires and analysed gut microbes in 456 participants.

People with the disorder had lower scores for healthful plant-based diets and ate more refined grains, sweets and sweeteners. Diet was associated with 84.3% of the gut microbes linked to the disorder. Over a median 4.2 years, 45 people with the disorder (15.7%) developed alpha-synucleinopathies, neurodegenerative diseases involving abnormal accumulation of the protein alpha-synuclein. Four dietary factors and five gut microbes were associated with progression. Higher coffee consumption was linked to a lower risk of progression.

Why it matters

For age-related neurodegenerative diseases, the work raises the question of whether diet–microbe interactions could offer targets for intervention before disease develops.

Caveats

This observational study cannot establish cause and effect, and participants reported their diets through questionnaires. The progression findings do not establish effects in people without this sleep disorder.

From the paper

Participants

This study included 287 iRBD patients and 208 controls matched for age (iRBD: 66.9 ± 7.1 years; controls: 66.6 ± 7.3 years) and sex (74.6 vs. 68.3% male).

Results, Clinical Characteristics

Follow-up

After a median follow-up of 4.2 years, 45 (15.7%) iRBD patients converted to α-synucleinopathies.

Methods

Result

We found that iRBD patients exhibited lower healthful PDIs (adjusted odds ratio [aOR] 95% confidence interval [95% CI]: 0.48 [0.29–0.80], P = 0.005) but higher consumption of unhealthful plant-based foods (refined grains, sweets, and sweeteners).

Results

Limitation

First, because iRBD patients exhibit varying degrees of neurodegeneration at baseline, we cannot definitively rule out reverse causality, wherein early prodromal symptoms (eg, subtle cognitive and autonomic dysfunction) may alter dietary choices.

Discussion

Quoted word for word from the full text on movementdisorders.onlinelibrary.wiley.com.